JNBA Financial Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
EFG
PI
DA
BPWM
PAS
YIH
JNBA Financial Advisors's ONCY Position: Q2 2026 in Review
JNBA Financial Advisors opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 210 shares worth $200. The stake represents ﹤0.01% of the portfolio and ranks #815 among its holdings. This is a return to the name: JNBA Financial Advisors previously reported a position in ONCY as recently as Q4 2025.
JNBA Financial Advisors first reported a position in ONCY in Q2 2018 and has held it in 31 quarters since. The position peaked at $1K in Q2 2021. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.
- JNBA Financial Advisors held 210 shares of Oncolytics Biotech worth $200 as of Q2 2026.
- Oncolytics Biotech was a new JNBA Financial Advisors position in Q2 2026.
- Oncolytics Biotech made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #815 holding.
- JNBA Financial Advisors first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 31 quarters since.
- JNBA Financial Advisors's Oncolytics Biotech position peaked at $1K in Q2 2021.
- 24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.